121 related articles for article (PubMed ID: 7498474)
1. Analysis of a novel defective HTLV-I provirus and detection of a new HTLV-I-induced cellular transcript.
Kubota S; Furuta RA; Siomi H; Maki M; Hatanaka M
FEBS Lett; 1995 Nov; 375(1-2):31-6. PubMed ID: 7498474
[TBL] [Abstract][Full Text] [Related]
2. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia.
Tamiya S; Matsuoka M; Etoh K; Watanabe T; Kamihira S; Yamaguchi K; Takatsuki K
Blood; 1996 Oct; 88(8):3065-73. PubMed ID: 8874205
[TBL] [Abstract][Full Text] [Related]
3. Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis.
Miyazaki M; Yasunaga J; Taniguchi Y; Tamiya S; Nakahata T; Matsuoka M
J Virol; 2007 Jun; 81(11):5714-23. PubMed ID: 17344291
[TBL] [Abstract][Full Text] [Related]
4. The diversity of the structure and genomic integration sites of HTLV-1 provirus in MT-2 cell lines.
Hashikura Y; Umeki K; Umekita K; Nomura H; Yamamoto I; Hasegawa H; Yanagihara K; Okayama A
Hum Cell; 2016 Jul; 29(3):122-9. PubMed ID: 26940204
[TBL] [Abstract][Full Text] [Related]
5. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms.
Taniguchi Y; Nosaka K; Yasunaga J; Maeda M; Mueller N; Okayama A; Matsuoka M
Retrovirology; 2005 Oct; 2():64. PubMed ID: 16242045
[TBL] [Abstract][Full Text] [Related]
6. HTLV-1 gene expression by defective proviruses in an infected T-cell line.
Bhat NK; Adachi Y; Samuel KP; Derse D
Virology; 1993 Sep; 196(1):15-24. PubMed ID: 8356792
[TBL] [Abstract][Full Text] [Related]
7. Long cellular repeats flanking a defective HTLV-I provirus: implication for site-targeted integration.
Kubota S; Furuta R; Maki M; Siomi H; Hatanaka M
Oncogene; 1993 Oct; 8(10):2873-7. PubMed ID: 8378096
[TBL] [Abstract][Full Text] [Related]
8. Clinical implication of the integration patterns of human T-cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma.
Shimamoto Y; Kobayashi M; Miyamoto Y
Leuk Lymphoma; 1996 Jan; 20(3-4):207-15. PubMed ID: 8624458
[TBL] [Abstract][Full Text] [Related]
9. HTLV-I provirus in the clinical subtypes of ATL.
Matsuoka M; Tamiya S; Takemoto S; Yamaguchi K; Takatsuki K
Leukemia; 1997 Apr; 11 Suppl 3():67-9. PubMed ID: 9209301
[TBL] [Abstract][Full Text] [Related]
10. p21X mRNA is expressed as a singly spliced pX transcript from defective provirus genomes having a partial deletion of the pol-env region in human T-cell leukemia virus type 1-infected cells.
Orita S; Kobayashi H; Aono Y; Saiga A; Maeda M; Igarashi H
Nucleic Acids Res; 1993 Aug; 21(16):3799-807. PubMed ID: 8367298
[TBL] [Abstract][Full Text] [Related]
11. Provirus Mutations of Human T-Lymphotropic Virus 1 and 2 (HTLV-1 and HTLV-2) in HIV-1-Coinfected Individuals.
Campos KR; Caterino-de-Araujo A
mSphere; 2020 Sep; 5(5):. PubMed ID: 32999083
[TBL] [Abstract][Full Text] [Related]
12. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
Shuh M; Hill SA; Derse D
Virology; 1999 Sep; 262(2):442-51. PubMed ID: 10502522
[TBL] [Abstract][Full Text] [Related]
13. Human T-cell leukemia virus type 1 (HTLV-1) infection of mice: proliferation of cell clones with integrated HTLV-1 provirus in lymphoid organs.
Tanaka M; Sun B; Fang J; Nitta T; Yoshida T; Kohtoh S; Kikukawa H; Hanai S; Uchida K; Miwa M
J Virol; 2001 May; 75(9):4420-3. PubMed ID: 11287593
[TBL] [Abstract][Full Text] [Related]
14. Defective human T-cell leukemia virus in adult T-cell leukemia patients.
Konishi H; Kobayashi N; Hatanaka M
Mol Biol Med; 1984 Aug; 2(4):273-83. PubMed ID: 6100561
[TBL] [Abstract][Full Text] [Related]
15. HTLV-1 proviruses encoding non-functional TAX in adult T-cell leukemia.
Okazaki S; Moriuchi R; Yosizuka N; Sugahara K; Maeda T; Jinnai I; Tomonaga M; Kamihira S; Katamine S
Virus Genes; 2001; 23(2):123-35. PubMed ID: 11724264
[TBL] [Abstract][Full Text] [Related]
16. Comparisons of defective HTLV-I proviruses predict the mode of origin and coding potential of internally deleted genomes.
Hill SA; Shuh M; Derse D
Virology; 1999 Oct; 263(2):273-81. PubMed ID: 10544101
[TBL] [Abstract][Full Text] [Related]
17. A novel therapeutic molecule against HTLV-1 infection targeting provirus.
Tanaka A; Takeda S; Kariya R; Matsuda K; Urano E; Okada S; Komano J
Leukemia; 2013 Aug; 27(8):1621-7. PubMed ID: 23411465
[TBL] [Abstract][Full Text] [Related]
18. 5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo.
Koiwa T; Hamano-Usami A; Ishida T; Okayama A; Yamaguchi K; Kamihira S; Watanabe T
J Virol; 2002 Sep; 76(18):9389-97. PubMed ID: 12186921
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo.
Mortreux F; Leclercq I; Gabet AS; Leroy A; Westhof E; Gessain A; Wain-Hobson S; Wattel E
J Natl Cancer Inst; 2001 Mar; 93(5):367-77. PubMed ID: 11238698
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human T cell leukaemia virus type I long terminal repeat expression by DNA methylation: implications for latency.
Cassens S; Ulrich U; Beimling P; Simon D
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3255-9. PubMed ID: 7964636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
